Journal of Renal Nutrition
Volume 11, Issue 4 , Pages 183-193 , October 2001

Protective effects of dietary phytoestrogens in chronic renal disease

References 

  1. Giovanetti S, Maggiore Q. A low nitrogen diet with protein of high biological value for severe chronic uremia. Lancet. 1964;1:1000–1003
  2. Berlyne GM, Shaw AB, Nilwarangkur S. Dietary treatment of chronic renal failure. Experience with a modified Giovanetti diet. Nephron. 1965;2:129–147
  3. Kopple JD, Coburn JW. Metabolic studies of low protein diets in uremia. I. Nitrogen and potassium. Medicine. 1973;52:583–595
  4. Barsotti G. Effects of dietary therapy on urmeic symptoms and complications. In:  Giovannetti S editors. Nutritional Therapy of Chronic Renal Failure. Boston, MA: Kluwer Academic; 1989;p. 235–240
  5. Mitch WE, Walser M. Nutritional therapy of the uremic patient. In: ed 5.  Brenner BM editors. The Kidney. Philadelphia, PA: Saunders; 1996;p. 2382–2423
  6. Walser M, Mitch WE, Maroni BJ, et al.  Should protein intake be restricted in pre dialysis patients. Kidney Int. 1999;55:771–779
  7. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis of aging, renal ablation, and intrinsic renal disease. N Engl J Med. 1982;307:652–659
  8. Klahr S, Buerkert J, Purkerson ML. Role of dietary factors in the progression of chronic renal disease. Kidney Int. 1983;24:579–587
  9. Rosman JB, ter Wee PM, Meijer S, et al.  Prospective randomized trial of early dietary protein restriction in chronic renal failure. Lancet. 1984;2:1291–1296
  10. Mitch WE, Walser M, Steinman TL, et al.  The effect of a ketoacid-amino acid supplement to a restricted diet on the progression of chronic renal failure. N Engl J Med. 1984;311:623–629
  11. Ihle BU, Becker GJ, Whitworth JA, et al.  The effect of protein restriction on the progression of renal insufficiency. N Engl J Med. 1989;321:1773–1777
  12. Walker JD, Dodds RA, Murrells TJ, et al.  Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet. 1989;2:1411–1414
  13. Zeller KR. Low protein diets in renal disease. Diabetes Care. 1991;14:856–866
  14. Fouque D, Laville M, Boissel JP, et al.  Controlled low protein diets in chronic renal insufficiency: Meta-analysis. BMJ. 1992;304:216–220
  15. Pedrini MT, Levey AS, Lau J, et al.  The effects of dietary protein restriction on the progression of diabetic and non-diabetic renal disease: A meta-analysis. Ann Intern Med. 1996;124:627–632
  16. Williams AJ, Walls J. Metabolic consequences of differing protein diets in experimental renal disease. Eur J Clin Invest. 1987;17:117–122
  17. Williams AJ, Baker F, Walls J. Effect of varying quantity and quality of dietary protein intake in experimental renal disease in rats. Nephron. 1987;46:83–90
  18. Barsotti G, Navalesi R, Giampietro O, et al.  Effects of a vegetarian, supplemented diet on renal function, proteinuria, and glucose metabolism in patients with “overt” diabetic nephropathy and renal insufficiency. Contrib Nephrol. 1988;65:87–94
  19. Jibani MM, Bloodworth LL, Foden E, et al.  Predominantly vegetarian diet in patients with incipient and early clinical diabetic nephropathy: Effects on albumin excretion rate and nutritional status. Diabet Med. 1991;8:949–953
  20. Wardle EN. Soy protein diet therapy in renal disease. Nephron. 1998;78:328–331
  21. Iwasaki K, Gleiser CA, Masoro EJ, et al.  The influence of dietary protein source on longevity and age-related disease processes of Fischer rats. J Gerontol. 1988;43:B5–B12
  22. Shimokawa I, Higami Y, Hubbard GB, et al.  Diet and the suitability of the male Fischer 343 rat as a model for aging research. J Gerontol. 1993;48:B27–B32
  23. Tomobe K, Philbrick DJ, Ogborn MR, et al.  Effect of dietary soy protein and genistein on disease progression in mice with polycystic kidney disease. Am J Kidney Dis. 1998;31:55–61
  24. Aukema HM, Housini I, Rawling JM. Dietary soy protein effects on inherited polycystic kidney disease are influenced by gender and protein level. J Am Soc Nephrol. 1999;10:300–308
  25. Ogborn MR, Bankovic-Calic N, Shoesmith C, et al.  Soy protein modification of rat polycystic kidney disease. Am J Physiol. 1998;274(3Pt2):F541–F549
  26. Ogborn MR, Nitschmann E, Weiler HA, et al.  Modification of polycystic kidney disease and fatty acid status by soy protein diet. Kidney Int. 2000;57:159–166
  27. D'Amico G, Gentile MG, Manna G, et al.  Effect of vegetarian soy diet on hyperlipidaemia in nephrotic syndrome. Lancet. 1992;339:1131–1134
  28. Gentile MG, Fellin G, Cofano F, et al.  Treatment of proteinuric patients with a vegetarian soy diet and fish oil. Clin Nephrol. 1993;40:315–320
  29. Soroka N, Silverberg DS, Greemland M, et al.  Comparison of a vegetable-based (soya) and an animal-based low-protein diet in predialysis chronic renal failure patients. Nephron. 1998;79:173–180
  30. Anderson JW, Blake JE, Turner J, et al.  Effects of soy protein on renal function and proteinuria in patients with type 2 diabetes. Am J Clin Nutr. 1998;68(Suppl 6):1347S–1353S
  31. Hall AV, Parbtani A, Clark WF, et al.  Abrogation of MRL/lpr lupus nephritis by dietary flaxseed. Am J Kidney Dis. 1993;22:326–332
  32. Theofilopolous AN, Dixon FJ. Murine models of systemic lupus erythematosus. Adv Immunol. 1985;37:269–290
  33. Ingram AJ, Parbtani A, Clark WF, et al.  Effects of flaxseed and flax oil diets in a rat-5/6 renal ablation model. Am J Kidney Dis. 1995;25:320–329
  34. Ogborn MR, Nitschmann E, Weiler H, et al.  Flaxseed ameliorates interstitial nephritis in rat polycystic kidney disease. Kidney Int. 1999;55:417–423
  35. Clark WF, Parbtani A, Huff MW, et al.  Flaxseed: A potential treatment for lupus nephritis. Kidney Int. 1995;48:475–480
  36. Martin PM, Horwitz KB, Ryan DS, et al.  Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology. 1978;103:1860–1867
  37. Miksicek RJ. Interaction of naturally occurring non-steroidal estrogens with expressed with recombinant human estrogen receptor. J Steroid Biochem Mol Biol. 1994;49:153–160
  38. Ros Barcelo A. Lignification in plant cell walls. In:  Jeon KW editors. International Review of Cytology. vol 176:San Diego, CA: Academic; 1997;p. 87–132
  39. Axelson M, Sjovall J, Gustafsson B, et al.  Soya—A dietary source of the non-steroidal oestrogen equol in humans and animals. J Endocrinol. 1984;102:49–56
  40. Coward L, Barnes NC, Setchell KDR, et al.  Genistein and daidzein, and their β-glycoside conjugates: Anti-tumor isoflavones in soy bean foods from American and Asian diets. J Agric Food Chem. 1993;41:1961–1967
  41. Wang H-J, Murphy PA. Isoflavone content in commercial soybean foods. J Agric Food Chem. 1994;42:1666–1673
  42. Wang H-J, Murphy PA. Isoflavone composition of American and Japanese soybean in Iowa: Effects of variety, crop year, and location. J Agric Food Chem. 1994;42:1674–1677
  43. Haytowitz DB, Matthews RH. Legumes and Legume Products. In: Washington, DC: United States Department of Agriculture; 1986;p. 1–156
  44. Young VR. Soy protein in relation to human protein and amino acid nutrition. J Am Diet Assoc. 1991;91:828–835
  45. Thompson LU, Robb P, Serraino M, et al.  Mammalian lignan production from various foods. Nutr Cancer. 1991;16:43–52
  46. Thompson LU, Rickard SE, Cheung F, et al.  Variability in anticancer lignan levels in flaxseed. Nutr Cancer. 1997;27:26–30
  47. Mazur W, Fotsis T, Wahala K, et al.  Isotope dilution gas chromatographic-mass spectrometric method for the determination of isoflavonoids, coumestrol, and lignans in food samples. Anal Biochem. 1996;233:169–180
  48. Slavin JL, Jacobs D, Marquart L. Grain processing and nutrition. Crit Rev Food Sci Nutr. 2000;40:309–326
  49. Setchell KDR, Adlercreutz H. Mammalian lignans and phyto-estrogens. Recent studies on their formation, metabolism and biologic role in health and disease. In:  Rowland I editors. Role of the Gut Flora in Toxicity and Cancer. Basel, Switzerland: Karger; 1988;p. 315–345
  50. Borriello SP, Setchel KDR, Axelson M. Production and metabolism of lignans by the human faecal flora. J Appl Bacteriol. 1985;58:37–43
  51. Axelson M, Setchell KDR. The excretion of lignans in rats: evidence for an intestinal bacterial source for this new group of compounds. FEBS Lett. 1981;123:337–342
  52. Rowland IR, Wiseman H, Sanders TA, et al.  Interindividual variation in metabolism of soy isoflavones and lignans: Influence of habitual diet on equol production by the gut microflora. Nutr Cancer. 2000;36:27–32
  53. Morton MS, Wilcox G, Wahlgvist ML, et al.  Determination of lignans and isoflavonoids in human female plasma following dietary supplementation. J Endocrinol. 1994;142:251–259
  54. Adlercreutz H, Fotsis T, Lampe J, et al.  Quantitative determination of lignans and isoflavones in plasma of omnivorous and vegetarian women by isotope-dilution gas chromatography-mass spectrometry. Scand J Clin Lab Invest. 1993;53(suppl 215):5–18
  55. Adlercreutz H, Markkanen H, Watanabe S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet. 1993;342:1209–1210
  56. Nesbitt PD, Lam Y, Thompson LU. Human metabolism of mammalian lignan precursors in raw and processed flaxseed. Am J Clin Nutr. 1999;69:549–555
  57. Lampe JW, Martini MC, Kurzer MS, et al.  Urinary lignan and isoflavonoid excretion in premenopausal women consuming flaxseed powder. Am J Clin Nutr. 1994;60:122–128
  58. Cunnane SC, Hamadeh MJ, Liede AC, et al.  Nutritional attributes of traditional flaxseed in healthy young adults. Am J Clin Nutr. 1995;61:62–68
  59. Rickard SE, Orcheson LJ, Seidl MM, et al.  Dose-dependent production of mammalian lignans in rats and in vitro from the purified precursor secoisolariciresinol diglycoside in flaxseed. J Nutr. 1996;126:2012–2019
  60. Setchell KDR. Phytoestrogens: The biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr. 1998;68:1333S–1348S
  61. Tham DM, Gardner CD, Haskell WL. Potential health benefits of dietary phytoestrogens: A review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab. 1998;83:2223–2235
  62. Markiewicz L, Garey J, Adlercreutz H, et al.  In vitro bioassays of non-steroidal phytoestrogens. J Steroid Biochem Mol Biol. 1993;45:399–405
  63. Kuiper GGJM, Lemmen JG, Carlsson B, et al.  Interaction of estrogenic chemicals and phytoestrogens with estrogen receptorβ. Endocrinology. 1998;139:4252–4263
  64. Taylor AH, Al-Azzawi F. Immunolocalisation of oestrogen receptor beta (ERβ) in human tissues. J Mol Endocrinol. 2000;24:145–155
  65. Hirano T, Fukuoka K, oka K, et al.  Antiproliferative activity of mammalian lignan derivatives against the human breast carcinoma cell line, ZR-75-1. Cancer Invest. 1990;8:595–601
  66. Serraino M, Thompson LU. The effect of flaxseed supplementation on the initiation and promotional stages of mammary tumorigenesis. Nutr Cancer. 1992;17:153–159
  67. Peterson G, Coward L, Barnes S. Isoflavones inhibit the growth of human prostate cancer cells in culture. Proc Am Assoc Cancer Res. 1992;33:57–64
  68. Yanajihara K, Ito A, Toge T, et al.  Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res. 1993;53:5815–5821
  69. Zava DT, Duwe G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer. 1997;27:31–40
  70. Wang TTY, Sathyamoorthy N, Phang JM. Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis. 1996;17:271–275
  71. Fotsis T, Pepper M, Adlercreutz H, et al.  Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci U S A. 1993;90:2690–2694
  72. Akiyama T, Ishida J, Nakagawa S, et al.  Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem. 1987;262:5592–5595
  73. Linassier C, Pierre M, LePecq JB, et al.  Mechanisms of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity. Biochem Pharmacol. 1990;39:187–193
  74. Okura A, Arakawa H, Oka H, et al.  Effect of genistein on topoisomerase activity and on the growth of [Val 12] Ha-ras-transformed NIH 3T3 cells. Biochem Biophys Res Commun. 1988;157:183–189
  75. Markovits J, Linassier C, Fosse P, et al.  Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res. 1989;49:5111–5117
  76. Kim H, Peterson TG, Barnes S. Mechanisms of action of the soy isoflavone genistein: Emerging role for its effects via transforming growth factor β signaling pathways. Am J Clin Nutr. 1998;68(suppl):1418S–1425S
  77. Wei HC, Wei LH, Frenkel K, et al.  Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutr Cancer. 1993;20:1–12
  78. Wei HC, Bowen R, Cai Q, et al.  Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med. 1995;208:124–130
  79. Record IR, Dreosti IE, McInerney JK. The antioxidant activity of genistein in vitro. J Nutr Biochem. 1995;6:481–485
  80. Kitts DD, Yuan YV, Wijewickreme AN, et al.  Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metablites enterodiol and enterolactone. Mol Cell Biochem. 1999;202:91–100
  81. Vedavanam K, Srijayanta S, O'Reilly J, et al.  Antioxidant action and potential antidiabetic properties of an isoflavonoid-containing soyabean phytochemical extract (SPE). Phytother Res. 1999;13:601–608
  82. Nakashima S, Koike T, Nozawa Y. Genistein, a protein tyrosine kinase inhibitor, inhibits thromboxane A2-mediated human platelet responses. Mol Pharmacol. 1991;39:475–480
  83. Asahi M, Yanagi S, Ohta S, et al.  Thombin-induced human platelet aggregation is inhibited by protein tyrosine-kinase inhibitors, ST638 and genistein. FEBS Lett. 1992;309:10–14
  84. Rendu F, Eldor A, Grelac F, et al.  Inhibition of platelet activation by tyrosine kinase inhibitors. Biochem Pharmacol. 1992;44:881–888
  85. McNicol A. The effects of genistein on platelet function are due to thromboxane receptor antagonism rather than inhibition of tyrosine kinase. Prostaglandins Leukot Essent Fatty Acids. 1992;48:379–384
  86. Shen TY, Hussaini IM. Kadsurenone and other related lignans as antagonists of platelet-activating factor receptor. Methods Enzymol. 1990;187:446–454
  87. Krol W, Czuba ZP, Threadgill MD, et al.  Inhibition of nitric oxide (NO) production in murine macrophages by flavones. Biochem Pharmacol. 1995;50:1031–1035
  88. Atluru D, Gudapaty S. Inhibition of bovine mononuclear cell proliferation, interleukin-2 synthesis, protein-tyrosine kinase and leukotiene-B(4) production by a protein-tyrosine kinase inhibitor, genistein. Vet Immunol Immunopathol. 1993;38:113–122
  89. Hirakata M, Kaname S, Chung UG, et al.  Tyrosine kinase dependent expression of TGF-beta induced by stretch in mesangial cells. Kidney Int. 1997;51:1028–1036
  90. Kato H, Osajima A, Uezono Y, et al.  Involvement of PDGF in pressure-induced mesangial cell proliferation through PKC and tyrosine kinase pathways. Am J Physiol. 1999;277(1Pt2):F105–F112
  91. Ha H, Roh DD, Kirschenbaum MA, et al.  Atherogenic lipoproteins enhance mesangial cell expression of platelet-derived growth factor: role of protein tyrosine kinase and cyclic AMP-dependent protein kinase. J Lab Clin Med. 1998;131:456–465
  92. Yokoo T, Kitamura M. Dual regulation of IL-1β-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-kB and AP-1. Am J Physiol. 1996;270(1 Pt 2):F123–F130
  93. Coyne DW, Morrison AR. Effect of tyrosine kinase inhibitor, genistein, on interleukin-1 stimulated PGE2 production in mesangial cells. Biochem Biophys Res Commun. 1990;73:718–724

☆ †Research Chemist, Phytonutrients Laboratory, Beltsville Human Nutrition Research Center, Agricultural Research Service, United States Department of Agriculture, Beltsville, MD.

☆☆ ‡Professor of Medicine, Division of Renal Diseases and Hypertension, George Washington University Medical Center, Washington, DC.

★ Address reprint requests to Manuel T. Velasquez, MD, Division of Renal Diseases and Hypertension, Department of Medicine, George Washington University Medical Center, 2150 Pennsylvania Avenue, NW, Washington, DC 20037.

PII: S1051-2276(01)70036-2

doi: 10.1016/S1051-2276(01)70036-2

Journal of Renal Nutrition
Volume 11, Issue 4 , Pages 183-193 , October 2001

Article Tools